Product Name: | Sertraline hydrochloride |
Synonyms: |
(1S,4S)-4-(3,4-DICHLOROPHENYL)-1,2,3,4-TETRAHYDRO-N-METHYL-1-NAPHTHALENAMINEHYDROCHLORIDE;
(1S,4S)-4-(3,4-DICHLOROPHENYL)-1,2,3,4-TETRAHYDRO-N-METHYL-1-NAPTHALENAMINEHYDROCHLORIDE; (1SChemicalbook,4S)-1-(3,4-DICHLOROPHENYL)-1,2,3,4-TETRAHYDRO-4-(METHYLAMINO)NAPHTHALENEHYDROCHLORIDE;SERTRALINEHCLFORMI;SERTRALINEHCLFORMII; SERTRALINEHYDROCHLORIDE;SERTRALINEMANDELATE;SETRALINEHCL |
CAS Number: | 79559-97-0 |
Molecular Formular: | C17H18Cl3N |
Molecular Weight: | 342.69 |
Appearance: | white powder |
Sertraline hydrochloride chemical Properties | |
Melting point | 246-249°C |
Density | 1.37 |
Kpa | pKa (water): 9.48 ± 0.04; pKa water, 40:60 v/v): 8.6; pKa (ethanol:water, 1:1 v/v): 8.5(at 25ºC) |
Stability | Store in Freezer |
CAS databases | 79559-97-0(CAS DataBase Reference) |
Sertraline HCI is used for a number of conditions, including major depressive disorder (MDD), obsessive-compulsive disorder (OCD), body dysmorphic disorder (BDD), posttraumatic stress disorder (PTSD), premenstrual dysphoric disorder (PMDD), panic disorder, and social anxiety disorder (SAD). It has also been used for premature ejaculation and vascular headaches but evidence of the effectiveness in treating those conditions is not robust.